Form 4: Ryan Specialty CEO Receives Stock Option Grant
Statement of Changes in Beneficial Ownership
Ryan Specialty Holdings CEO Timothy William Turner was granted 168,577 stock options exercisable at $29.66 per share.
Summary
- Timothy William Turner, CEO of Ryan Specialty Holdings, Inc., received a grant of 168,577 stock options.
- The options have an exercise price of $29.66 per share.
- The options vest in equal installments on July 1, 2029, 2030, and 2031.
- The expiration date for these options is May 5, 2036.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a routine regulatory disclosure regarding executive compensation with no immediate impact on company operations or financial health.
Positives
- Long-term incentive alignment for the CEO through multi-year vesting schedule.
- Grant approved by the compensation and governance committee, ensuring regulatory compliance.
Negatives
- Dilutive impact on existing shareholders upon future exercise of options.
Risks
- Potential for future share price volatility affecting the value of the granted options.
- Market conditions may impact the ability to exercise options profitably by the 2036 expiration date.
Future Outlook
The filing does not provide forward-looking financial guidance, focusing solely on the disclosure of executive equity compensation.
Industry Context
StockSavvy.ai notes that equity-based compensation for C-suite executives is standard practice in the insurance brokerage and specialty risk sector to align management interests with long-term shareholder value.
Comparison to Industry Standards
- The use of multi-year vesting schedules (2029-2031) is consistent with industry best practices for executive retention.
- The grant size and exercise price are typical for a company of Ryan Specialty's market capitalization and growth profile.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Equity Compensation Grant | Grant of 168,577 stock options to the CEO approved by the compensation and governance committee. | 05/05/2026 | Standard governance procedure for executive incentive alignment. |
Stakeholder Impact
- Shareholders may experience minor dilution upon the eventual exercise of these options.
Next Steps
- Vesting of options beginning July 1, 2029.
Key Dates
| Date | Description |
|---|---|
| 05/05/2026 | Date of the stock option grant transaction. |
| 05/07/2026 | Date of filing the Form 4. |
| 07/01/2029 | First vesting date for the granted options. |
| 05/05/2036 | Expiration date of the stock options. |
Keywords
Ryan Specialty, RYAN, Form 4, Insider Trading, Stock Options, Executive Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.